Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT07386405
Starting soon Observational

Validation and Cultural Adaptation of the KOOS-ACL Scale for the Italian Population

NCT07386405 · tracked via the Priya Life Science Italy tracker
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Phase
Observational
Started
2026-01-19
Last updated
2026-02-04

Condition(s) studied

Scale Reliability ValidityACL InjuryValidation and Cultural Adaptation of a ScalePROMs

Investigational drug(s) / intervention(s)

PROMS submition

PROMS submition: KOOS ACL submission to validate and transalte the scale for italian people

Study summary

Submission of the KOOS ACL questionnaires in Italian for the purpose of validation and cultural adaptation of the KOOS-ACL scale for the Italian population.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient age 18 years or older * Patients who are native Italian speakers * Patients undergoing anterior cruciate ligament reconstruction of the knee * Patients who have understood and signed the informed consent to participate in the study. * Patients who are able to understand the study conditions and participate for the entire duration Exclusion Criteria: * Patients unable to understand the text in Italian * Patients undergoing knee replacement surgery, corrective osteotomies, or osteosynthesis of knee fractures. * Patients who are drug addicts, alcoholics, suffer from psychiatric disorders, or have any clinical conditions that could compromise the success of the questionnaire. * Patients with orthopedic conditions of other origins

Primary outcome measure(s)

  • validated translation and cultural adaptation of the KOOS-ACL scale in Italian. — 18 months

Trial sites (1)

FacilityCityRegionStatus
Istituto Clinico San Siro Milan Italy

More I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials in Italy

Prepare II - Predictive Model Training and External Validation Recruiting
Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC Recruiting
Total Ankle Replacement: Clinical and Radiological Outcomes Recruiting
GREENWATER 2.0: Reducing Iodinated Contrast Agents in Hospital Wastewater Recruiting
Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity Recruiting

Other trials for the same condition

Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimen Recruiting
ACL Reconstruction with a New Generation of LARS Artificial Ligament Active, not recruiting
Validation of the Italian Version of the Forgotten Joint Score (FJS-12) in Total Ankle Replacement Recruiting
ACL Reconstruction in Patients Aged 50 Years and Older Active, not recruiting
Study of Functional Magnetic Resonance Signal Variations in Patients Undergoing Anterior Cruciate Ligament Reconstruction With the Application of a Dedicated Neuromotor Training Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07386405 on ClinicalTrials.gov ↗ ← All trials in Italy